Isotechnika voclosporin study in AJT
October 5, 2011 by leonardzehr · Leave a Comment
Tweet Isotechnika Pharma’s (TSX:ISA) PROMISE study has been published in the American Journal of Transplantation, one of the most respected journals in transplant medicine. The PROMISE study was a Phase 2b, 6-month, randomized, open-label study of three concentration-controlled groups of voclosporin, low, medium, and high, compared with tacrolimus in 334 low-risk kidney transplantation recipients at [...]
